Ashley M. Mackey - 22 Mar 2026 Form 4/A - Amendment Insider Report for Sanara MedTech Inc. (SMTI)

Reporting relationship: Controller
Issuer ticker: SMTI
Reported as of: 22 Mar 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 05 May 2026, 16:05:20 UTC
Original report date: 23 Mar 2026
Prior SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Ashley M. Mackey

Key filing fact

Ashley M. Mackey filed Form 4/A - Amendment for Sanara MedTech Inc. (SMTI) on 05 May 2026.

Key facts

This page summarizes Ashley M. Mackey's Form 4/A - Amendment filing for Sanara MedTech Inc. (SMTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 May 2026, 16:05.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002084457 Primary reporting owner

Mackey Ashley M

Relationship: Controller
Address: 1200 SUMMIT AVE, SUITE 414, FORT WORTH
Signature: /s/ Ashley M. Mackey
Signature date: 05 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMTI transaction

Common Stock

Award

Transaction value
Shares: +2,804
Change %: +130%
Price: $0.000000^*
Shares after: 4,967
Date: 22 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.

Footnote F2

The original Form 4, filed on March 23, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of the Issuer reported as being beneficially owned by the reporting person. The original Form 4 mistakenly indicated that the reporting person held 5,067 shares of common stock, when in fact, as reported in this amendment, the reporting person held 4,967 shares of common stock following the reported transaction.